Stay updated with breaking news from 21835210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com cut shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) from a strong-buy rating to a buy rating in a research report report published on Friday morning. Several other brokerages have also issued reports on CORT. Truist Financial lifted their target price on shares of Corcept Therapeutics from $36.00 to $42.00 and gave the company […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The firm had revenue of $135.41 million for the quarter, compared to analysts’ expectations of $129.27 million. Corcept Therapeutics […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 19,320,000 shares, an increase of 23.3% from the January 15th total of 15,670,000 shares. Based on an average trading volume of 1,340,000 shares, the days-to-cover ratio […]